Advertisement
UK markets close in 2 hours 45 minutes
  • FTSE 100

    8,111.28
    +32.42 (+0.40%)
     
  • FTSE 250

    19,784.04
    +182.06 (+0.93%)
     
  • AIM

    754.75
    +1.63 (+0.22%)
     
  • GBP/EUR

    1.1671
    +0.0014 (+0.12%)
     
  • GBP/USD

    1.2514
    +0.0003 (+0.03%)
     
  • Bitcoin GBP

    51,424.37
    +504.18 (+0.99%)
     
  • CMC Crypto 200

    1,387.95
    -8.58 (-0.61%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.30
    +0.73 (+0.87%)
     
  • GOLD FUTURES

    2,357.60
    +15.10 (+0.64%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,044.16
    +126.88 (+0.71%)
     
  • CAC 40

    8,043.63
    +26.98 (+0.34%)
     

A Look at Globus Medical’s Segmental Performance

A Look at Globus Medical’s Segmental Performance

Globus Medical (GMED) classifies its products into innovative fusion products and disruptive technology products. Sales of innovative fusion products rose to $80.2 million in 3Q17 compared to $68.4 million in 3Q16. The increase was attributable to the increase from Alphatec’s international sales.